Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.

NCT01707745 is registered in ClinicalTrials.gov with Sivakami A Pai as lead sponsor.

NCT NCT01707745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01707745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.
Lead sponsor
Sivakami A Pai
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2010
Completion date
December 31, 2012
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage 2+ or stage 3+ retinopathy of prematurity in zone i or zone ii.